A
CCRN icon

AJOVista’s Cross Country Healthcare CCRN Stock Holding History

AJOVista’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-330
Closed -$7.47K – 139
2023
Q4 		$7.47K Buy
+330
New +$7.16K 0.01% 441

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AJOVista's CCRN Position: Q1 2024 in Review

AJOVista sold out of Cross Country Healthcare (CCRN) in Q1 2024, closing a stake of 330 shares — an estimated $7.47K sold.

AJOVista first reported a position in CCRN in Q4 2023 and held it in 1 quarter. The position peaked at $7.47K in Q4 2023. 175 funds tracked by Wall St. Rank hold CCRN as of Q1 2024.

  • AJOVista reported no remaining Cross Country Healthcare position as of Q1 2024 after selling out during the quarter.
  • AJOVista sold 330 Cross Country Healthcare shares in Q1 2024, an estimated $7.47K.
  • AJOVista first reported a position in Cross Country Healthcare in Q4 2023 and held it in 1 quarter.
  • AJOVista's Cross Country Healthcare position peaked at $7.47K in Q4 2023.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.